SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sherman Bernard C, et al. – ‘SC 13D/A’ on 12/23/03 re: Barr Pharmaceuticals Inc

On:  Tuesday, 12/23/03, at 12:14pm ET   ·   Accession #:  950136-3-3164   ·   File #:  5-42092

Previous ‘SC 13D’:  ‘SC 13D/A’ on 10/23/03   ·   Next:  ‘SC 13D’ on 12/29/03   ·   Latest:  ‘SC 13D/A’ on 7/11/06

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/23/03  Sherman Bernard C                 SC 13D/A               1:18K  Barr Pharmaceuticals Inc          Capital Systems 01/FA
          The Bernard Sherman 2000 Trust

Amendment to General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment to Schedule 13D                             12     43K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Common Stock
SC 13D/A1st Page of 12TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10)* Barr Laboratories, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 068306109 (CUSIP Number) Meyer F. Florence 150 Signet Drive Weston, Ontario, Canada M9L 1T9 (416) 749-9300 (Name, Address and Telephone Number of Person Authorized to Received Notices and Communications) December 15, 2003 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SC 13D/A2nd Page of 12TOC1stPreviousNextBottomJust 2nd
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Bernard C. Sherman 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 11,250 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 11,250 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,895,676 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN 2
SC 13D/A3rd Page of 12TOC1stPreviousNextBottomJust 3rd
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The Bernard Sherman 2000 Trust 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO 3
SC 13D/A4th Page of 12TOC1stPreviousNextBottomJust 4th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Sherman Holdings Inc. 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 4
SC 13D/A5th Page of 12TOC1stPreviousNextBottomJust 5th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Shermco Inc. 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 5
SC 13D/A6th Page of 12TOC1stPreviousNextBottomJust 6th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Sherfam Inc. 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 6
SC 13D/A7th Page of 12TOC1stPreviousNextBottomJust 7th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Apotex Holdings Inc. 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 7
SC 13D/A8th Page of 12TOC1stPreviousNextBottomJust 8th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) SHERMFIN INC. 22-2416614 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 8
SC 13D/A9th Page of 12TOC1stPreviousNextBottomJust 9th
SCHEDULE 13D CUSIP No. 068306109 1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Sherman Delaware, Inc. 13-3083682 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) --- (b) X --- 3) SEC USE ONLY 4) SOURCE OF FUNDS 5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA NUMBER OF 7) SOLE VOTING POWER SHARES 0 BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 9,884,426 EACH 9) SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH 10) SHARED DISPOSITIVE POWER 9,884,426 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,884,426 12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.7% 14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC, CO 9
SC 13D/A10th Page of 12TOC1stPreviousNextBottomJust 10th
The Reporting Persons (as defined below) hereby amend and supplement the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on March 26, 1999, as amended by Amendment No. 1 filed with the SEC on July 1, 1999, as amended by Amendment No. 2 filed with the SEC on June 14, 2001, as amended by Amendment No. 3 filed with the SEC on December 24, 2002, as amended by Amendment No. 4 filed with the SEC on February 19, 2003, as amended by Amendment No. 5 filed with the SEC on March 7, 2003, as amended by Amendment No. 6 filed with the SEC on May 19, 2003, as amended by Amendment No. 7 filed with the SEC on August 21, 2003, as amended by Amendment No. 8 filed with the SEC on September 19, 2003 and as further amended by Amendment No. 9 filed with the SEC on October 23, 2003 (the "Schedule") as follows: This Schedule relates to the common stock, par value $.01 per share ("Common Stock"), of Barr Laboratories, Inc., a Delaware corporation (the "Issuer"). "Item 5. Interest in Securities of the Issuer. Items 5(a) and (b) of the Schedule are hereby amended by deleting the existing text and inserting the following text in its stead: [Enlarge/Download Table] Amount Sole Power to Shared Power to Sole Power to Shared Power to Reporting Person Beneficially Percent of Vote or Vote or Dispose or Direct Dispose or Direct Owned (1) Class Direct the Vote Direct the Vote the Disposition of the Dispostion of 1. Dr. Sherman 9,895,676(2) 14.7 11,250 9,884,426(2) 11,250 9,884,426(2) 2. Sherman Trust 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 3. Sherman Holdings 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 4. Shermco 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 5. Shermfam 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 6. Apotex 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 7. Shermfin 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) 8. SDI 9,884,426(2) 14.7 0 9,884,426(2) 0 9,884,426(2) (1) All share amounts have been adjusted from those disclosed in Amendments 1 through 5 to the Schedule to reflect the 3-for-2 stock split effected in the form of a 50% stock dividend distributed on March 17, 2003. (2) By virtue of the relationships described in Item 2(a) above, Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin may be deemed to possess indirect beneficial ownership of the shares of Common Stock beneficially owned by SDI. The filing of this statement by Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin shall not be construed as an admission that any of Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex or Shermfin, is, for the purposes of Section 13(d) or Section 13(g) of the Act, the beneficial owner of any securities covered by this statement. Because of the relationships described in Item 2(a) above, the Reporting Persons may be deemed to constitute a "group" within the meaning of Rule 13d-5 under the Act, and as such, each member of the group would be deemed to beneficially own, in the aggregate, all the shares of Common Stock held by members of the group. The Reporting Persons disclaim membership in a group." Item 5(c) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead: 10
SC 13D/A11th Page of 12TOC1stPreviousNextBottomJust 11th
"Other than as described below and in Amendment No. 9 to the Schedule, there were no transactions in the Company's Common Stock effected by the Reporting Persons during the past sixty days. All of the transactions set forth below were effected by the sale by SDI of such shares of Common Stock in open market transactions pursuant to Rule 144 under the Securities Act of 1933, as amended. Trade Date No. of Shares Price Per Share ---------- ------------- --------------- 12/15/2003 6,600 $73.8 12/15/2003 4,400 $73.85 12/15/2003 2,000 $73.88 12/15/2003 3,200 $74 12/15/2003 3,400 $74.02 12/15/2003 600 $74.04 12/15/2003 7,100 $74.05 12/15/2003 900 $74.06 12/15/2003 3,800 $74.1 12/15/2003 800 $74.12 12/15/2003 3,300 $74.15 12/15/2003 700 $74.17 12/15/2003 1,600 $74.21 12/15/2003 2,600 $74.25 12/15/2003 800 $74.26 12/15/2003 1,300 $74.27 12/15/2003 700 $74.28 12/15/2003 300 $74.29 12/15/2003 100 $74.35 12/15/2003 700 $74.4 12/15/2003 1,000 $74.41 12/15/2003 600 $74.43 12/15/2003 1,300 $74.45 12/15/2003 100 $74.47 12/15/2003 1,300 $74.5 12/15/2003 1,100 $74.52 12/15/2003 700 $74.53 12/15/2003 600 $74.54 12/15/2003 100 $74.55 12/15/2003 500 $74.56 12/15/2003 300 $74.64 12/15/2003 2,400 $74.65 12/15/2003 700 $74.68 12/15/2003 2,600 $74.71 12/15/2003 400 $74.73 12/15/2003 200 $74.74 12/15/2003 100 $74.75 12/15/2003 800 $74.77 12/15/2003 1,400 $74.78 12/15/2003 500 $74.81 12/15/2003 1,400 $74.89 12/15/2003 1,400 $74.9 12/15/2003 1,200 $74.91 12/15/2003 1,900 $74.93 12/15/2003 500 $74.94 12/15/2003 10,600 $75 12/15/2003 4,500 $75.03 12/15/2003 300 $75.07 12/15/2003 400 $75.12 12/15/2003 900 $75.17 12/15/2003 600 $75.21 12/15/2003 11,000 $75.22 12/15/2003 1,500 $75.23 12/15/2003 600 $75.24 12/15/2003 2,500 $75.25 12/15/2003 200 $75.26 12/17/2003 300 $73.77 12/17/2003 100 $73.79 12/17/2003 2,200 $73.8 12/17/2003 1,100 $73.81 12/17/2003 700 $73.82 12/17/2003 600 $73.83 12/17/2003 400 $73.84 12/17/2003 1,400 $73.85 12/17/2003 200 $73.86 12/17/2003 3,100 $73.89 12/17/2003 26,400 $73.9 12/17/2003 400 $73.91 12/17/2003 100 $73.92 12/17/2003 1,600 $73.93 12/17/2003 500 $73.94 12/17/2003 7,100 $73.95 12/17/2003 600 $73.96 12/17/2003 500 $73.98 12/17/2003 200 $73.99 12/17/2003 8,400 $74 12/17/2003 300 $74.01 12/17/2003 9,800 $74.03 12/17/2003 1,500 $74.04 12/17/2003 1,000 $74.05 12/17/2003 1,000 $74.06 12/17/2003 800 $74.07 12/17/2003 2,700 $74.08 12/17/2003 1,200 $74.1 12/17/2003 500 $74.11 12/17/2003 200 $74.12 12/17/2003 500 $74.13 12/17/2003 600 $74.15 12/17/2003 1,000 $74.18 12/17/2003 10,800 $74.2 12/17/2003 100 $74.21 12/17/2003 600 $74.23 12/17/2003 1,300 $74.24 12/17/2003 2,200 $74.25 12/17/2003 2,500 $74.5 12/17/2003 5,500 $74.52 12/18/2003 25,000 $76.3 12/18/2003 300 $76.27 12/18/2003 200 $76.26 12/18/2003 23,400 $76.25 11
SC 13D/ALast Page of 12TOC1stPreviousNextBottomJust 12th
Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: December 23, 2003 /s/ Bernard C. Sherman ---------------------- BERNARD C. SHERMAN THE BERNARD SHERMAN 2000 TRUST By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman Sole Trustee SHERMAN HOLDINGS INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman President SHERMCO INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman Chairman SHERFAM INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman Chairman APOTEX HOLDINGS INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman President SHERMFIN, INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman President SHERMAN DELAWARE, INC. By: /s/ Bernard C. Sherman ---------------------- Bernard C. Sherman President 12

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13D/A’ Filing    Date First  Last      Other Filings
Filed on:12/23/03124
12/15/0314
10/23/03104,  DEF 14A,  PRE 14A,  SC 13D/A,  SC 13G
9/19/0310SC 13D/A
8/21/0310SC 13D/A
5/19/0310SC 13D/A
3/17/0310
3/7/0310SC 13D/A
2/19/0310SC 13D/A
12/24/0210SC 13D/A
6/14/0110SC 13D/A
7/1/9910SC 13D
3/26/9910SC 13D
 List all Filings 
Top
Filing Submission 0000950136-03-003164   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 11:07:43.2am ET